Dynavax Technologies Corp
DVAX
Revenue
73.80M
▲23.01M▲45.29%
3 Months ChangeAssets
1.02B
▲29.76M▲3.02%
3 Months ChangeLiabilities
373.47M
▲5.39M▲1.46%
3 Months ChangeFree Cash Flow
-17.43M
▼-43.77M▼-166.17%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 8-K
ID: 0001193125-24-246522
2024-08-06
Form 10-Q
ID: 0000950170-24-091804
2024-08-06
Form 8-K
ID: 0000950170-24-091760
2024-08-02
Form 8-K
ID: 0000950170-24-089940
2024-05-24
Form 8-K
ID: 0000950170-24-064556
2024-05-08
Form 10-Q
ID: 0000950170-24-055653
2024-05-08
Form 8-K
ID: 0000950170-24-055612
2024-04-01
Form 8-K
ID: 0000950170-24-039305
2024-03-12
Form 8-K
ID: 0000950170-24-029912
2024-02-22
Form 8-K
ID: 0000950170-24-018747